Free Trial

13 Stocks With Strong Institutional Buying - 9 of 13

 
 

Cencora (NYSE:COR)

Net Inflows of from Institutional Investors in Dollars
$10,047,031,828.00
Net Inflows of from Institutional Investors in Shares
43,996,462
Number of Institutional Transactions in the Last 90 Days
827

Inflows and Outflows by Quarter for Cencora (NYSE:COR)

Cencora logoCencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. Read More 
 
 

Sell NVDA Now? (Ad)

Hundreds of hedge funds are fleeing this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shift

Get the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock